Skip to main content
Journal cover image

The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.

Publication ,  Journal Article
Habib, AS; Gan, TJ
Published in: J Clin Anesth
February 2005

STUDY OBJECTIVES: To compare the effectiveness of treating established postoperative nausea and vomiting (PONV) with an antiemetic acting at a different receptor with that of treating PONV with the antiemetic used for prophylaxis. DESIGN: Analysis of data collected in a previously published randomized, double-blind, placebo-controlled study. SETTING: Outpatient surgical procedures from 50 institutions in North America. PATIENTS: Patients (N = 2061) undergoing outpatient surgical procedures planned to last no more than 2 hours. INTERVENTIONS: Patients were randomized to receive ondansetron 4 mg, droperidol 1.25, droperidol 0.625 mg, or placebo. In the postoperative anesthesia care unit, patients who developed PONV received rescue antiemetics at the discretion of the attending anesthesiologist. The following antiemetics were used for rescue: ondansetron 4 mg, droperidol 0.625 to 1.25 mg, metoclopramide 10 mg, promethazine 6.25 to 25 mg, and dimenhydrinate 25 to 50 mg. MEASUREMENTS: The complete response rate (no nausea, no emesis, and no need for further rescue) after administration of the rescue antiemetic in patients with established PONV was calculated. The complete response rate after administration of each of the different rescue antiemetics was compared with that after administration of the same antiemetic used for PONV prophylaxis. MAIN RESULTS: In patients who failed prophylaxis with ondansetron 4 mg, the complete response rate was significantly higher (P = .02) after rescue with promethazine 6.25 to 25 mg (78%) than after rescue with ondansetron 4 mg (46%). In patients who failed prophylaxis with droperidol 0.625 and 1.25 mg, the complete response rate was significantly higher after rescue with promethazine 6.25 to 25 mg (77%; P = .02) and dimenhydrinate 25 to 50 mg (78%; P = .04) than after rescue with droperidol 0.625 to 1.25 mg (56%). CONCLUSION: In patients who failed prophylaxis with ondansetron or droperidol, promethazine was significantly more effective than the agent used for prophylaxis for the treatment of PONV. In patients who failed prophylaxis with droperidol, dimenhydrinate was also more effective than droperidol for the treatment of established PONV in the postoperative anesthesia care unit.

Duke Scholars

Published In

J Clin Anesth

DOI

ISSN

0952-8180

Publication Date

February 2005

Volume

17

Issue

1

Start / End Page

62 / 65

Location

United States

Related Subject Headings

  • Treatment Failure
  • Randomized Controlled Trials as Topic
  • Promethazine
  • Postoperative Nausea and Vomiting
  • Ondansetron
  • North America
  • Multicenter Studies as Topic
  • Middle Aged
  • Metoclopramide
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Habib, A. S., & Gan, T. J. (2005). The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report. J Clin Anesth, 17(1), 62–65. https://doi.org/10.1016/j.jclinane.2004.04.004
Habib, Ashraf S., and Tong J. Gan. “The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.J Clin Anesth 17, no. 1 (February 2005): 62–65. https://doi.org/10.1016/j.jclinane.2004.04.004.
Habib, Ashraf S., and Tong J. Gan. “The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.J Clin Anesth, vol. 17, no. 1, Feb. 2005, pp. 62–65. Pubmed, doi:10.1016/j.jclinane.2004.04.004.
Journal cover image

Published In

J Clin Anesth

DOI

ISSN

0952-8180

Publication Date

February 2005

Volume

17

Issue

1

Start / End Page

62 / 65

Location

United States

Related Subject Headings

  • Treatment Failure
  • Randomized Controlled Trials as Topic
  • Promethazine
  • Postoperative Nausea and Vomiting
  • Ondansetron
  • North America
  • Multicenter Studies as Topic
  • Middle Aged
  • Metoclopramide
  • Male